Holen Sie sich die Stockscreener-App
70.33
2.05%
1.41
Schlusskurs vom Vortag:
$68.92
Offen:
$69.5
24-Stunden-Volumen:
4.84M
Relative Volume:
0.93
Marktkapitalisierung:
$12.51B
Einnahmen:
$803.32M
Nettoeinkommen (Verlust:
$-709.10M
KGV:
-9.0163
EPS:
-7.8003
Netto-Cashflow:
$-212.68M
1W Leistung:
+6.13%
1M Leistung:
+3.26%
6M Leistung:
+17.28%
1J Leistung:
+102.39%
1-Tages-Spanne:
$68.57
$71.88
1-Wochen-Bereich:
$66.08
$76.33
52-Wochen-Spanne:
$34.35
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Firmenname
Tempus Ai Inc
Sektor
Branche
Telefon
800-976-5448
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Vergleichen Sie TEM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
70.33 | 12.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
VEEV
Veeva Systems Inc
|
222.21 | 35.99B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
DOCS
Doximity Inc
|
41.26 | 7.73B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
85.37 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.20 | 7.14B | 11.99B | 24.18M | 234.31M | 0.2956 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-09-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-21 | Eingeleitet | BTIG Research | Buy |
| 2025-02-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Fortgesetzt | TD Cowen | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-09 | Eingeleitet | Guggenheim | Buy |
| 2024-11-11 | Herabstufung | Stifel | Buy → Hold |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-12 | Eingeleitet | Piper Sandler | Neutral |
| 2024-07-09 | Eingeleitet | BofA Securities | Buy |
| 2024-07-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-07-09 | Eingeleitet | Longbow | Buy |
| 2024-07-09 | Eingeleitet | Loop Capital | Buy |
| 2024-07-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-07-09 | Eingeleitet | Needham | Buy |
| 2024-07-09 | Eingeleitet | Stifel | Buy |
| 2024-07-09 | Eingeleitet | TD Cowen | Buy |
| 2024-07-09 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Top Artificial Intelligence Stocks To Add to Your WatchlistJanuary 15th - MarketBeat
Best Artificial Intelligence Stocks To Watch NowJanuary 6th - MarketBeat
Tempus AI, Inc. Stock (TEM) Opinions on FDA Clearance and Financial Results - Quiver Quantitative
JPM26: Tempus AI and the push toward precision medicine - Yahoo Finance
Tempus AI approaching profitability despite GAAP losses - MSN
Why is Tempus AI stock surging 11% premarket today? - MSN
4 Hyper-Growth Stocks Ready to Dazzle This Earnings Season - Investing.com
Jobs Data: Is Tempus AI Inc stock a value trapPortfolio Growth Summary & High Return Trade Guides - baoquankhu1.vn
New Highs: Is Tempus AI Inc stock a value trapJuly 2025 Action & Fast Gaining Stock Reports - baoquankhu1.vn
Promising Artificial Intelligence Stocks To Watch TodayJanuary 13th - MarketBeat
Promising Artificial Intelligence Stocks To Follow TodayJanuary 4th - MarketBeat
Tempus AI (TEM) Soars 15% on $1.1-Billion Deal - Insider Monkey
TEM's Collab for Oncology Patient Population Is Gaining Attention - Yahoo Finance Singapore
Tempus AI, Inc. $TEM Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Lefkofsky sees more runway ahead for now-profitable Tempus - Crain's Chicago Business
SG Americas Securities LLC Sells 15,137 Shares of Tempus AI, Inc. $TEM - MarketBeat
Is Tempus AI (TEM) Pricing Reflect Its AI Healthcare Story After Strong 1 Year Run? - Yahoo Finance
Tempus AI achieved a record $1.1B in contracts for 2025 - Investorsobserver
Nvidia and Tempus drive AI transformation in Korea-linked drug discovery and manufacturingCHOSUNBIZ - Chosunbiz
Why Tempus AI Stock Rose Today - Finviz
Record 2025 Revenue and New Cancer Data Deals Might Change The Case For Investing In Tempus AI (TEM) - simplywall.st
Why Tempus AI stock rose today - MSN
JPM26, Day 1: Waystar rolls out agentic AI; Intermountain CEO addresses political upheaval - Fierce Healthcare
JPM Kicks Off With Alnylam In the Red; But Others Surge - Investor's Business Daily
Tempus AI (NASDAQ:TEM) Shares Gap UpStill a Buy? - MarketBeat
Why Tempus AI Stock Is Trading Higher On Monday? - Benzinga
Why Tempus AI Stock Jumped on Monday? - GuruFocus
Tempus Shares Jump After Strong Preliminary 2025 Results - Yahoo Finance
Tempus AI's Pharma Momentum Accelerates - GuruFocus
Northwestern Medicine Selects Tempus AI, Inc. to Expand Genomic Testing - marketscreener.com
Tempus and NYU Langone partner on cancer genomic research - Investing.com
Tempus and NYU Langone partner on cancer genomic research By Investing.com - Investing.com South Africa
Promising Artificial Intelligence Stocks To Keep An Eye OnJanuary 12th - MarketBeat
Here’s why the Tempus AI stock may surge 47% soon - CryptoRank
Nancy Pelosi's Latest Trades Are Heating Up — Tempus AI's 100% Stock Surge Is Leading The Charge - Benzinga
Tempus AI rises on better-than-expected sales numbers - Sherwood News
Tempus Pre Announcing Strong Data (NASDAQ:TEM) - Seeking Alpha
Tempus AI shares jump after company posts record $1.1BN contract backlog - MSN
Why Is Tempus AI Stock Surging 11% Premarket Today? - Menafn
Tempus AI stock pops 12% premarket after $1.1 billion contracts update — what traders watch next - TechStock²
AI and cancer: how Tempus and NYU Langone team up to study tumors over time - Stock Titan
Tempus AI (TEM) Stock: Why Big Pharma Is Betting Big on This AI Platform - Blockonomi
Tempus AI Stock Rallies 105% in a Year: Should Investors Still Hold? - Yahoo Finance
Northwestern Medicine and Tempus partner to expand cancer genomic testing - Investing.com Canada
S&P 500 Futures Fall in Premarket Trading; Tempus AI, Klarna Group Lead - Barron's
Northwestern Medicine and Tempus partner to expand cancer genomic testing By Investing.com - Investing.com South Africa
Tempus AI stock soars after achieving record $1.1 billion contract value - Investing.com Nigeria
Tempus AI stock soars after achieving record $1.1 billion contract value By Investing.com - Investing.com South Africa
Northwestern Medicine Selects Tempus to Expand Genomic Testing - The Joplin Globe
Tempus AI Reports Strong Preliminary 2025 Revenue Growth - TipRanks
Tempus AI climbs on $1.1 billion contract value - TradingView — Track All Markets
Finanzdaten der Tempus Ai Inc-Aktie (TEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
1.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):